William Chung - ECGI Holdings CEO Directors
| ECGI Stock | USD 0 0.0002 22.22% |
Insider
William Chung is CEO Directors of ECGI Holdings
| Age | 31 |
| Phone | 323-968-2030 |
| Web | https://www.ecgiholdings.com |
ECGI Holdings Management Efficiency
The company has return on total asset (ROA) of (0.203) % which means that it has lost $0.203 on every $100 spent on assets. This is way below average. ECGI Holdings' management efficiency ratios could be used to measure how well ECGI Holdings manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Karen Santiago | Catalent | 53 | |
| Z Mahdavi | Catalent | N/A | |
| Maria Sigwald | Transportadora de Gas | 52 | |
| William MD | Viemed Healthcare | 66 | |
| Dean Scarborough | Cardinal Health | 64 | |
| Casey Hoyt | Viemed Healthcare | 47 | |
| Steven Esq | Catalent | 61 | |
| Sheri Edison | Cardinal Health | 63 | |
| Robert LLB | Viemed Healthcare | 50 | |
| Michael CRT | Viemed Healthcare | 47 | |
| Karen Flynn | Catalent | 56 | |
| Michael Freeman | Viemed Healthcare | N/A | |
| Kay Schmidt | Catalent | 61 | |
| Martin Nestor | Transportadora de Gas | 66 | |
| Brenda Schroer | Aris Water Solutions | 48 | |
| Horacio Turri | Transportadora de Gas | 58 | |
| Walter Graziano | Transportadora de Gas | 59 | |
| Lisa PE | Aris Water Solutions | N/A | |
| Rick Carpenter | Tandem Diabetes Care | 61 | |
| Jordan MD | Avadel Pharmaceuticals PLC | 46 | |
| Steven Sullivan | Avadel Pharmaceuticals PLC | 59 | |
Management Performance
| Return On Asset | -0.2 |
ECGI Holdings Leadership Team
Elected by the shareholders, the ECGI Holdings' board of directors comprises two types of representatives: ECGI Holdings inside directors who are chosen from within the company, and outside directors, selected externally and held independent of ECGI. The board's role is to monitor ECGI Holdings' management team and ensure that shareholders' interests are well served. ECGI Holdings' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, ECGI Holdings' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Danny Wong, Acting Consultant | ||
| Nicholas Bozza, Chief Officer | ||
| Julie Singleton, CEO of Breastcare Division and Director | ||
| Joseph Hashim, VP Marketing | ||
| William Chung, CEO Directors | ||
| Richard Owsik, Consultant |
ECGI Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is ECGI Holdings a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Asset | -0.2 | |||
| Current Valuation | 2.88 M | |||
| Shares Outstanding | 6.52 M | |||
| Shares Owned By Insiders | 45.63 % | |||
| Price To Earning | (0.11) X | |||
| Price To Book | 35.20 X | |||
| EBITDA | (3.06 M) | |||
| Net Income | (3.57 M) | |||
| Cash And Equivalents | 131.85 K | |||
| Cash Per Share | 0.01 X |
Currently Active Assets on Macroaxis
Other Information on Investing in ECGI Pink Sheet
ECGI Holdings financial ratios help investors to determine whether ECGI Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ECGI with respect to the benefits of owning ECGI Holdings security.